Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
75
LNSR Quote, Financials, Valuation and Earnings
Last price:
$7.77
Seasonality move
:
25.37%
Day range:
$7.35 - $7.88
52-week range:
$2.67 - $8.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.80x
P/B ratio:
3.93x
Volume:
42.6K
Avg. volume:
48.3K
1-year change:
191.67%
Market cap:
$89.4M
Revenue:
$42.2M
EPS (TTM):
-$1.46
Analysts' Opinion
-
Consensus RatingLENSAR has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, LENSAR has an estimated upside of 42.86% from its current price of $7.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $7.70.
Fair Value
-
According to the consensus of 0 analysts, LENSAR has 42.86% upside to fair value with a price target of -- per share.
LNSR vs. S&P 500
-
Over the past 5 trading days, LENSAR has overperformed the S&P 500 by 4.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
LENSAR does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
LENSAR has grown year-over-year revenues for 6 quarters straight. In the most recent quarter LENSAR reported revenues of $13.5M.
Earnings Growth
-
LENSAR has grown year-over-year earnings for 0 quarters straight. In the most recent quarter LENSAR reported earnings per share of -$0.13.
Enterprise value:
71.4M
EV / Invested capital:
3.14x
Price / LTM sales:
1.80x
EV / EBIT:
--
EV / Revenue:
1.46x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-10.79x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$23.9M
Return On Assets:
-25.19%
Net Income Margin (TTM):
-34.03%
Return On Equity:
-56.16%
Return On Invested Capital:
-56.16%
Operating Margin:
-9.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $36.3M | $40.3M | $48.9M | $9.8M | $13.5M | |
| Gross Profit | $19.1M | $22.4M | $23.9M | $4.9M | $6.3M | |
| Operating Income | -$21.5M | -$11.9M | -$8.6M | -$2M | -$1.2M | |
| EBITDA | -$18.2M | -$8.4M | -$4.9M | -$1.2M | -$239K | |
| Diluted EPS | -$2.14 | -$1.68 | -$1.46 | -$0.23 | -$0.13 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $60M | $46.7M | $32.2M | $48.6M | $39.4M | |
| Total Assets | $80.7M | $68.1M | $54.8M | $70.9M | $62M | |
| Current Liabilities | $8.3M | $8M | $9.8M | $11M | $11.7M | |
| Total Liabilities | $11.8M | $11.1M | $12.2M | $34.5M | $39.3M | |
| Total Equity | $68.9M | $57M | $42.6M | $36.4M | $22.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.8M | -$13.9M | -$6.4M | -$339K | $3.2M | |
| Cash From Investing | -$214K | -$248K | -$8.1M | -$2K | -$905K | |
| Cash From Financing | -- | $19.8M | $52K | -$205K | -$93K | |
| Free Cash Flow | -$11.1M | -$14.2M | -$6.6M | -$341K | $3.1M | |
LNSR
Sector
Market Cap
$89.4M
$44.6M
Price % of 52-Week High
94.25%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
191.67%
-29.09%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$7.61
200-day SMA
Buy
Level
$4.84
Bollinger Bands (100)
Buy
Level
4.3 - 6.92
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Buy
Level
$7.57
Relative Strength Index (RSI14)
Buy
Level
57.25
ADX Line
Sell
Level
8.8
Williams %R
Neutral
Level
-36.6667
50-day SMA
Buy
Level
$6.70
MACD (12, 26)
Buy
Level
0.24
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Sell
Level
-1.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.9651)
Sell
CA Score
(Annual)
Level (-0.6155)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.4735)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
Stock Forecast FAQ
In the current month, LNSR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LNSR average analyst price target in the past 3 months is --.
-
Where Will LENSAR Stock Be In 1 Year?
According to analysts, the consensus estimate is that LENSAR share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About LENSAR?
Analysts are divided on their view about LENSAR share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LENSAR is a Sell and believe this share price will drop from its current level to --.
-
What Is LENSAR's Price Target?
The price target for LENSAR over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LNSR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for LENSAR is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LNSR?
You can purchase shares of LENSAR via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LENSAR shares.
-
What Is The LENSAR Share Price Today?
LENSAR was last trading at $7.77 per share. This represents the most recent stock quote for LENSAR. Yesterday, LENSAR closed at $7.70 per share.
-
How To Buy LENSAR Stock Online?
In order to purchase LENSAR stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
